C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
12/2004
12/29/2004	EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490048A1 Pharmaceutical composition for preventing or treating respiratory disease
12/29/2004	EP1490014A2 Photosensitive adhesive composition
12/29/2004	EP1334094B1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004	EP1226135B1 Method for preparing a thiophene derivative
12/29/2004	EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1182142C Substituted five-membered heterocyclic compounds, fungicidal compositions containing same and methods of making thereof
12/29/2004	CN1182103C Novel ethylamine derivatives
12/29/2004	CA2534094A1 Glycosidase inhibitors and methods of synthesizing same
12/29/2004	CA2529297A1 Therapeutic agents
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2528603A1 Thienopyridone derivatives as kinase inhibitors
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835745 Treating or inhibiting osteoporosis or bone demineralization, inflammatory bowel disease, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometriosis, endometrial cardiovascular disease, Alzheimer's disease
12/28/2004	US6835739 Benzamides and related inhibitors of factor Xa
12/28/2004	US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/28/2004	CA2126072C Tri-substituted phenyl derivatives and processes for their preparation
12/23/2004	WO2004111028A1 Cyclic onium compounds and glucosidase inhibitors
12/23/2004	WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110983A2 New benzamides as pparϒ modulators
12/23/2004	WO2004064771A3 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
12/23/2004	WO2004031109A3 Chiral diols, their manufacture and ligands and catalysts derived therefrom
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259920 Acne treatment
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
12/23/2004	US20040259877 Inhibitors against the production and release of inflammatory cytokines
12/23/2004	US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents
12/23/2004	US20040258954 Comprising an aryl group with bi-attachments of thiophene, furan, pyrrole ring; no absorption intensity in the visible light, low ionization potential, hole injection; use in blue light emitting device
12/23/2004	CA2528231A1 New benzamides as ppar.gamma. modulators
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/22/2004	EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1487796A1 Substituted biaryl amides as c5a receptor modulators
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487779A1 Oligofluorenylene compounds
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487430A1 Methods for treating diseases related to intraocular pressure
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	CN1556803A New organic compounds for electroluminescence and oganic electroluminescent devices using the same
12/22/2004	CN1556788A Muscarinic agonists
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/21/2004	US6833385 3-heteroarylalkyl substituted GABA analogs
12/21/2004	US6833200 Luminescent device with a triarylamine compound
12/16/2004	WO2004108685A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	WO2004108683A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
12/16/2004	WO2004108673A2 Inhibitors of papilloma virus
12/16/2004	WO2004089882A3 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/16/2004	US20040254237 Acid amide derivatives, process for producing these, and pest agent containing these
12/16/2004	US20040254158 1,1-Disubstituted cycloalkyl derivatives as factor Xa inhibitors
12/16/2004	US20040251563 preparing organic compounds by producing aryllithium compounds and reacting them with suitable electrophiles; a lithium compound is first generated by reacting halogen compounds with lithium metal and is then reacted with aromatic compounds to deprotonate them and form the desired lithium aromatics
12/16/2004	DE10324533A1 Stabile Lösungen von organischen halbleitenden Verbindungen Stable solutions of organic semiconducting compounds
12/16/2004	CA2528093A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	CA2526506A1 Inhibitors of papilloma virus
12/15/2004	EP1486494A1 N-substituted benzothiophenesulfonamide derivative
12/15/2004	EP1486493A1 3-hydroxy-3-(2-thienyl)propionamide compound, process for producing the same, and process for producing 3-amino-1-(2-thienyl)-1-propanol compound therefrom
12/15/2004	EP1486486A2 Substituted B-thiocarboxylic acids
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485079A2 Small molecule entry inhibitors
12/15/2004	EP1409476B1 Pharmaceutical compounds with serotonin receptor activity
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP1034783B1 Amide derivatives for the treatment of retinal neurodegenerative disorders
12/15/2004	EP0863755B1 Antithrombotic diamines
12/15/2004	CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004	CN1554654A Synthetic method for thiagabine and its raceme and S-configuration and its method for preparing amorphous powder
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831193 Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
12/14/2004	US6831106 Vitamin D analogues
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/09/2004	WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use
12/09/2004	WO2004106289A1 Protease inhibitors
12/09/2004	WO2004106285A1 Benzamide nitrile derivatives
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	US20040249170 Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040248983 Potent analgesic and antiinflammatory effects; antiinflammatory agents; treatment of pain and inflammation; N-(3-cyclohexylphenyl)-4-hydroxy-3-methoxyphenylacetamide
12/09/2004	US20040248952 Novel bicyclic compounds and compositions
12/09/2004	US20040248949 carbocyclic carboxy nitriles such as 4-chloro-N-[2-({[(1S)-1-cyano-2-thien-3-ylethyl]amino}carbonyl)cyclohexyl]benzamide, used as cathepsin inhibitors; antimetastatic and antitumor agents; prophylaxis of cardiovascular and bone disorders
12/09/2004	US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004	US20040248850 Compounds for the treatment of HIV infection
12/09/2004	US20040248815 Substituted amino acids as erythropoietin mimetics
12/09/2004	CA2527819A1 Optical sensors based on hybrid aptamer/conjugated polymer complexes
12/09/2004	CA2527632A1 Benzamide nitrile derivatives
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade

1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 329